You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
發改委:支持生物領域龍頭企業牽頭組建創新聯合體
國家發改委印發《「十四五」生物經濟發展規劃》提出,強化企業創新主體地位,要發揮生物領域龍頭企業引領支撐作用,引導大企業向產業鏈上下游開放科技創新、供應鏈、金融服務等資源,推動與中小企業融通創新。圍繞生物醫藥、生物農業、生物製造等規模大、影響廣的重點領域,鼓勵生物創新企業深耕細分領域,厚植發展優勢,培育成為具有全球競爭力的單項冠軍。
規劃還提出,要以促進關鍵技術突破和科技成果轉化應用為目標,支持生物領域龍頭企業牽頭組建創新聯合體,承擔建設產業創新中心、工程研究中心、技術創新中心及製造業創新中心等創新平台,並鼓勵生物技術領域創新創業,支持中小微企業發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.